Srinagar Observer
Friday, July 11, 2025
  • Home
  • Top News
  • Kashmir
  • Jammu
  • Business
  • Sports
  • National
  • World
  • Editorial

    The Habitual Shifts

    Assuring Crime Free Society

    Stimulating Young Energy

    An Ethical Denial

    Beating Inflation

    The Timely Exigence

    Extension in Academics

     Aiding Healthcare

    Development in Disguise

    Gender-Free Conviction

  • Edit-Oped
  • ePaper
No Result
View All Result
Srinagar Observer
  • Home
  • Top News
  • Kashmir
  • Jammu
  • Business
  • Sports
  • National
  • World
  • Editorial

    The Habitual Shifts

    Assuring Crime Free Society

    Stimulating Young Energy

    An Ethical Denial

    Beating Inflation

    The Timely Exigence

    Extension in Academics

     Aiding Healthcare

    Development in Disguise

    Gender-Free Conviction

  • Edit-Oped
  • ePaper
No Result
View All Result
Srinagar Observer
No Result
View All Result
Home Latest

DRDO issues directions on usage of anti-COVID drug 2-DG

SO NEWS Desk by SO NEWS Desk
June 1, 2021
in Latest, Top News
A A
0
Share on FacebookShare on TwitterWhatsApp

New Delhi, Jun 1 (PTI) The DRDO on Tuesday issued directions on the usage of its 2-DG drug on COVID-19 patients, stating that caution should be exercised while prescribing this medicine to people who have comorbidites such as uncontrolled diabetes, severe cardiac problem and acute respiratory distress syndrome.
The Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients in early May.

The first batch of this oral drug, developed by the Defence Research and Development Organisation (DRDO), was released on May 17 by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.

RELATED POSTS

Sakeena Itoo reviews healthcare scenario in Budhal, Surankote assembly constituencies

CM Omar inaugurates Travel & Tourism Fair Kolkata-2025

On Tuesday, the DRDO on Twitter issued “directions for usage of this drug for COVID-19 patients as per DCGI approval”.

“Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe COVID-19 patients for maximum duration up to 10 days,” it mentioned.

Uncontrolled diabetes, severe cardiac problem, acute respiratory distress syndrome, severe hepatic and renal impairment patients have not been studied yet with 2DG, hence caution should be exercised, it noted.

“2DG should not be given to pregnant and lactating women and patients below 18 years,” it stated.

Patients or their attendants are advised to request their hospital to contact Dr Reddy’s Laboratories (DRL) for medicine supply.

The anti-COVID-19 therapeutic application of 2-DG drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of DRDO, in collaboration with DRL.

The DRDO said the drug is approved for emergency use as adjunct therapy to the standard treatment of COVID-19 patients in the hospital settings.

The defence ministry on May 8 said that the clinical trials of 2-DG showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

The approval of the drug has come at a time India has been grappling with a record-breaking wave of coronavirus pandemic that has stretched the country’s healthcare infrastructure to its limit.

The drug comes in powder form in sachet and is taken orally by dissolving it in water.

In efficacy trends, the defence ministry said, patients treated with 2-DG showed faster symptomatic cure than the standard of care on various endpoints.

Related

ShareTweetSend
SO NEWS Desk

SO NEWS Desk

Related Posts

Sakeena Itoo reviews healthcare scenario in Budhal, Surankote assembly constituencies

by SO NEWS Desk
July 10, 2025
0

SRINAGAR, JULY 10: Minister for Health and Medical Education, Social Welfare and Education, Sakeena Itoo, today chaired a meeting at...

CM Omar inaugurates Travel & Tourism Fair Kolkata-2025

by SO NEWS Desk
July 10, 2025
0

Mutual tourism growth possible between J&K and West Bengal: CM KOLKATA, JULY 10: Jammu and Kashmir Chief Minister Omar Abdullah...

Promote SKICC for MICE tourism, improve visibility of JKTDC rooms: CM Omar

by SO NEWS Desk
July 10, 2025
0

SRINAGAR, JULY 9: Chief Minister Omar Abdullah today chaired the Board meetings of Sher-i- Kashmir International Convention Centre (SKICC) and...

GMC Srinagar achieves feat, performs 10 consecutive primary PCIs in 24 hrs

by SO NEWS Desk
July 7, 2025
0

SRINAGAR, JULY 07 - The Cardiology Department of Government Medical College (GMC) Srinagar has achieved a remarkable milestone by successfully...

SANJY-2025: LG Sinha visits Nunwan base camp at Pahalgam

by SO NEWS Desk
July 7, 2025
0

Interacts with Pilgrims, officials, service providers, langar sevadars, sanitation workers; reviews Yatra arrangement SRINAGAR, JULY 07: Lieutenant Governor Shri Manoj...

Next Post

Amid pandemic, SKIMS Bemina offering a helping hand to drug abuse victims

Bangladesh Cabinet minister's mobile phone snatched by mugger in Dhaka's street

Digital Edition

Srinagar Observer

Srinagar Observer is an English Newspaper based in Jammu and Kashmir

CATEGORY

  • Business
  • Edit-Oped
  • Editorial
  • Jammu
  • Kashmir
  • Latest
  • National
  • Photo Gallery
  • Sports
  • Top News
  • Uncategorized
  • World

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 9,375 other subscribers

Archives

No Result
View All Result
  • Home
  • About Us
  • Contact Us
  • Advertise

© 2024 Srinagar Observer - Designed by GITS.

No Result
View All Result
  • Home
  • Top News
  • Kashmir
  • Jammu
  • Business
  • Sports
  • National
  • World
  • Editorial
  • Edit-Oped
  • ePaper

© 2024 Srinagar Observer - Designed by GITS.